An interdisciplinary research team from Leipzig University and the Saxon AI center ScaDS.AI has developed a novel approach ...

In January, the U.S. Food and Drug Administration (FDA) issued its first guidance on the use of artificial intelligence (AI) models in ...

Intelligent Omics' Dr Rob Grundy discusses how combining AI with big data can lead to better drug discovery processes and that partnerships can help more organisations leverage cutting-edge tools.

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Drug discovery has long been plagued by high costs, inefficiencies and high failure rates. Therefore, many companies are now adopting AI to accelerate innovation and improve outcomes across every ...

Conduit has completed the first phase of a strategic collaboration with Sarborg Limited, integrating advanced AI and cybernetics into its drug development processes. The partnership aims to ...

Conduit is planning how to effectively integrate an advanced platform-driven approach powered by artificial intelligence and cybernetics to expedite drug development, while continuing to advance ...

WAKEFIELD, Mass., Jan. 28, 2025 /PRNewswire/ -- Glance, a leading provider of Guided Customer Experience (CX) solutions, published its AI + Human Maturity Model™ for Customer Experience ...

“We were very idealistic, believing that, together with AI and robotics, we could enhance the efficiency of drug development and reduce its cost, so that pharma companies could still make a ...